Thrombomodulin is essential for maintaining quiescence in vascular endothelial cells
Thrombomodulin (TM) is a thrombin receptor on endothelial cells that is involved in promoting activation of the anticoagulant protein C pathway during blood coagulation. TM also exerts protective anti-inflammatory properties through a poorly understood mechanism. In this study, we investigated the i...
Saved in:
| Published in: | Proceedings of the National Academy of Sciences - PNAS Vol. 118; no. 11 |
|---|---|
| Main Authors: | , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
16.03.2021
|
| Subjects: | |
| ISSN: | 1091-6490, 1091-6490 |
| Online Access: | Get more information |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Thrombomodulin (TM) is a thrombin receptor on endothelial cells that is involved in promoting activation of the anticoagulant protein C pathway during blood coagulation. TM also exerts protective anti-inflammatory properties through a poorly understood mechanism. In this study, we investigated the importance of TM signaling to cellular functions by deleting it from endothelial cells by CRISPR-Cas9 technology and analyzed the resultant phenotype of TM-deficient (
) cells. Deficiency of TM in endothelial cells resulted in increased basal permeability and hyperpermeability when stimulated by thrombin and TNF-α. The loss of the basal barrier permeability function was accompanied by increased tyrosine phosphorylation of VE-cadherin and reduced polymerization of F-actin filaments at cellular junctions. A significant increase in basal NF-κB signaling and expression of inflammatory cell adhesion molecules was observed in
cells that resulted in enhanced adhesion of leukocytes to
cells in flow chamber experiments. There was also a marked increase in expression, storage, and release of the von Willebrand factor (VWF) and decreased storage and release of angiopoietin-2 in
cells. In a flow chamber assay, isolated platelets adhered to
cells, forming characteristic VWF-platelet strings. Increased VWF levels and inflammatory foci were also observed in the lungs of tamoxifen-treated ERcre-TM
mice. Reexpression of the TM construct in
cells, but not treatment with soluble TM, normalized the cellular phenotype. Based on these results, we postulate cell-bound TM endows a quiescent cellular phenotype by tightly regulating expression of procoagulant, proinflammatory, and angiogenic molecules in vascular endothelial cells. |
|---|---|
| AbstractList | Thrombomodulin (TM) is a thrombin receptor on endothelial cells that is involved in promoting activation of the anticoagulant protein C pathway during blood coagulation. TM also exerts protective anti-inflammatory properties through a poorly understood mechanism. In this study, we investigated the importance of TM signaling to cellular functions by deleting it from endothelial cells by CRISPR-Cas9 technology and analyzed the resultant phenotype of TM-deficient (
) cells. Deficiency of TM in endothelial cells resulted in increased basal permeability and hyperpermeability when stimulated by thrombin and TNF-α. The loss of the basal barrier permeability function was accompanied by increased tyrosine phosphorylation of VE-cadherin and reduced polymerization of F-actin filaments at cellular junctions. A significant increase in basal NF-κB signaling and expression of inflammatory cell adhesion molecules was observed in
cells that resulted in enhanced adhesion of leukocytes to
cells in flow chamber experiments. There was also a marked increase in expression, storage, and release of the von Willebrand factor (VWF) and decreased storage and release of angiopoietin-2 in
cells. In a flow chamber assay, isolated platelets adhered to
cells, forming characteristic VWF-platelet strings. Increased VWF levels and inflammatory foci were also observed in the lungs of tamoxifen-treated ERcre-TM
mice. Reexpression of the TM construct in
cells, but not treatment with soluble TM, normalized the cellular phenotype. Based on these results, we postulate cell-bound TM endows a quiescent cellular phenotype by tightly regulating expression of procoagulant, proinflammatory, and angiogenic molecules in vascular endothelial cells. Thrombomodulin (TM) is a thrombin receptor on endothelial cells that is involved in promoting activation of the anticoagulant protein C pathway during blood coagulation. TM also exerts protective anti-inflammatory properties through a poorly understood mechanism. In this study, we investigated the importance of TM signaling to cellular functions by deleting it from endothelial cells by CRISPR-Cas9 technology and analyzed the resultant phenotype of TM-deficient (TM-/- ) cells. Deficiency of TM in endothelial cells resulted in increased basal permeability and hyperpermeability when stimulated by thrombin and TNF-α. The loss of the basal barrier permeability function was accompanied by increased tyrosine phosphorylation of VE-cadherin and reduced polymerization of F-actin filaments at cellular junctions. A significant increase in basal NF-κB signaling and expression of inflammatory cell adhesion molecules was observed in TM-/- cells that resulted in enhanced adhesion of leukocytes to TM-/- cells in flow chamber experiments. There was also a marked increase in expression, storage, and release of the von Willebrand factor (VWF) and decreased storage and release of angiopoietin-2 in TM-/- cells. In a flow chamber assay, isolated platelets adhered to TM-/- cells, forming characteristic VWF-platelet strings. Increased VWF levels and inflammatory foci were also observed in the lungs of tamoxifen-treated ERcre-TMf/f mice. Reexpression of the TM construct in TM-/- cells, but not treatment with soluble TM, normalized the cellular phenotype. Based on these results, we postulate cell-bound TM endows a quiescent cellular phenotype by tightly regulating expression of procoagulant, proinflammatory, and angiogenic molecules in vascular endothelial cells.Thrombomodulin (TM) is a thrombin receptor on endothelial cells that is involved in promoting activation of the anticoagulant protein C pathway during blood coagulation. TM also exerts protective anti-inflammatory properties through a poorly understood mechanism. In this study, we investigated the importance of TM signaling to cellular functions by deleting it from endothelial cells by CRISPR-Cas9 technology and analyzed the resultant phenotype of TM-deficient (TM-/- ) cells. Deficiency of TM in endothelial cells resulted in increased basal permeability and hyperpermeability when stimulated by thrombin and TNF-α. The loss of the basal barrier permeability function was accompanied by increased tyrosine phosphorylation of VE-cadherin and reduced polymerization of F-actin filaments at cellular junctions. A significant increase in basal NF-κB signaling and expression of inflammatory cell adhesion molecules was observed in TM-/- cells that resulted in enhanced adhesion of leukocytes to TM-/- cells in flow chamber experiments. There was also a marked increase in expression, storage, and release of the von Willebrand factor (VWF) and decreased storage and release of angiopoietin-2 in TM-/- cells. In a flow chamber assay, isolated platelets adhered to TM-/- cells, forming characteristic VWF-platelet strings. Increased VWF levels and inflammatory foci were also observed in the lungs of tamoxifen-treated ERcre-TMf/f mice. Reexpression of the TM construct in TM-/- cells, but not treatment with soluble TM, normalized the cellular phenotype. Based on these results, we postulate cell-bound TM endows a quiescent cellular phenotype by tightly regulating expression of procoagulant, proinflammatory, and angiogenic molecules in vascular endothelial cells. |
| Author | Cai, Xiaofeng Weiler, Hartmut Biswas, Indranil Panicker, Sumith R Giri, Hemant Rezaie, Alireza R |
| Author_xml | – sequence: 1 givenname: Hemant surname: Giri fullname: Giri, Hemant organization: Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104 – sequence: 2 givenname: Sumith R orcidid: 0000-0001-8550-9436 surname: Panicker fullname: Panicker, Sumith R organization: Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104 – sequence: 3 givenname: Xiaofeng surname: Cai fullname: Cai, Xiaofeng organization: Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104 – sequence: 4 givenname: Indranil orcidid: 0000-0003-2479-0249 surname: Biswas fullname: Biswas, Indranil organization: Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104 – sequence: 5 givenname: Hartmut surname: Weiler fullname: Weiler, Hartmut organization: Blood Research Institute, Blood Center of Wisconsin, Milwaukee, WI 53226 – sequence: 6 givenname: Alireza R orcidid: 0000-0002-5302-0553 surname: Rezaie fullname: Rezaie, Alireza R email: ray-rezaie@omrf.org organization: Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104 |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33836597$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkEtLAzEUhYNU7EPX7iRLN1PznCRLKVaFgpu6HtI8bCSTtJMZwX_vFCu4OJzL4buXy5mDScrJAXCL0RIjQR8OSZclQYQQJjGWF2CGkcJVzRSa_JunYF7KJ0JIcYmuwJRSSWuuxAxst_sut7vcZjvEkGAo0JXiUh90hD53sNUh9aNC-oDHIbhiXDIOjuiXLmaIuoMu2dzvXTytGBdjuQaXXsfibs6-AO_rp-3qpdq8Pb-uHjeV4Yz3lWQ7Ra1Ehntea4aMscxiX1NnifFES1PXigvqNWZEiTFnjGnChRTYe2HIAtz_3j10-Ti40jdtKKcPdHJ5KA3hGBMmKKIjendGh13rbHPoQqu77-avCfIDmItjUA |
| CitedBy_id | crossref_primary_10_1016_j_jtha_2024_03_024 crossref_primary_10_1016_j_jbc_2025_110339 crossref_primary_10_3892_mmr_2024_13220 crossref_primary_10_3389_fcell_2022_963866 crossref_primary_10_1016_j_bbamcr_2024_119891 crossref_primary_10_1016_j_jtha_2024_06_012 crossref_primary_10_1016_j_resplu_2024_100618 crossref_primary_10_1186_s13054_022_04070_5 crossref_primary_10_1016_j_rpth_2023_100085 crossref_primary_10_1038_s41598_024_74347_y crossref_primary_10_3390_ijms24065669 crossref_primary_10_26599_NR_2025_94907661 crossref_primary_10_1111_hepr_13802 crossref_primary_10_1016_j_thromres_2025_109302 crossref_primary_10_1016_j_gene_2023_148011 crossref_primary_10_1186_s12951_023_01808_3 crossref_primary_10_3390_ijms26104873 crossref_primary_10_1002_acn3_51930 crossref_primary_10_1111_jth_15490 crossref_primary_10_1016_j_jtha_2024_01_006 crossref_primary_10_1038_s41422_023_00820_4 crossref_primary_10_1038_s41583_024_00892_0 crossref_primary_10_1186_s43556_024_00226_7 crossref_primary_10_1002_poh2_46 crossref_primary_10_1161_ATVBAHA_123_320185 crossref_primary_10_1177_10760296251319963 crossref_primary_10_1016_j_jtha_2023_06_024 crossref_primary_10_1016_j_mvr_2024_104746 crossref_primary_10_1038_s41467_024_48328_8 crossref_primary_10_3389_fmed_2022_916620 crossref_primary_10_1161_ATVBAHA_123_320000 crossref_primary_10_1177_10815589241288515 crossref_primary_10_1093_cvr_cvad076 crossref_primary_10_1097_SHK_0000000000002632 crossref_primary_10_2147_JIR_S535854 crossref_primary_10_1186_s40001_023_01612_7 crossref_primary_10_1016_j_eujim_2025_102452 crossref_primary_10_1016_j_thromres_2023_10_001 crossref_primary_10_2147_JIR_S504184 crossref_primary_10_1161_ATVBAHA_123_320616 crossref_primary_10_1016_j_cellsig_2025_111699 crossref_primary_10_1097_MD_0000000000034373 |
| ContentType | Journal Article |
| DBID | NPM 7X8 |
| DOI | 10.1073/pnas.2022248118 |
| DatabaseName | PubMed MEDLINE - Academic |
| DatabaseTitle | PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Sciences (General) |
| EISSN | 1091-6490 |
| ExternalDocumentID | 33836597 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: R01 HL117132 – fundername: NHLBI NIH HHS grantid: R01 HL062565 – fundername: NHLBI NIH HHS grantid: R01 HL101917 |
| GroupedDBID | --- -DZ -~X .55 0R~ 123 29P 2AX 2FS 2WC 4.4 53G 5RE 5VS 85S AACGO AAFWJ AANCE ABBHK ABOCM ABPLY ABPPZ ABTLG ABXSQ ABZEH ACGOD ACIWK ACNCT ACPRK AENEX AEUPB AEXZC AFFNX AFOSN AFRAH ALMA_UNASSIGNED_HOLDINGS BKOMP CS3 D0L DCCCD DIK DU5 E3Z EBS F5P FRP GX1 H13 HH5 HYE IPSME JAAYA JBMMH JENOY JHFFW JKQEH JLS JLXEF JPM JSG JST KQ8 L7B LU7 N9A NPM N~3 O9- OK1 PNE PQQKQ R.V RHF RHI RNA RNS RPM RXW SA0 SJN TAE TN5 UKR VQA W8F WH7 WOQ WOW X7M XSW Y6R YBH YIF YIN YKV YSK ZCA ~02 ~KM 7X8 |
| ID | FETCH-LOGICAL-c545t-84b93d80c5f56a40ccd4d1f63ed2cf2a8c669573fa1429763e444a257871ff7c2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 49 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000629635100068&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1091-6490 |
| IngestDate | Sun Nov 09 11:00:48 EST 2025 Wed Feb 19 02:28:33 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 11 |
| Keywords | VWF PAR1 inflammation CRISPR-Cas9 thrombomodulin |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c545t-84b93d80c5f56a40ccd4d1f63ed2cf2a8c669573fa1429763e444a257871ff7c2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0003-2479-0249 0000-0001-8550-9436 0000-0002-5302-0553 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/7980409 |
| PMID | 33836597 |
| PQID | 2511247303 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2511247303 pubmed_primary_33836597 |
| PublicationCentury | 2000 |
| PublicationDate | 2021-03-16 |
| PublicationDateYYYYMMDD | 2021-03-16 |
| PublicationDate_xml | – month: 03 year: 2021 text: 2021-03-16 day: 16 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Proceedings of the National Academy of Sciences - PNAS |
| PublicationTitleAlternate | Proc Natl Acad Sci U S A |
| PublicationYear | 2021 |
| SSID | ssj0009580 |
| Score | 2.5560346 |
| Snippet | Thrombomodulin (TM) is a thrombin receptor on endothelial cells that is involved in promoting activation of the anticoagulant protein C pathway during blood... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| Title | Thrombomodulin is essential for maintaining quiescence in vascular endothelial cells |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/33836597 https://www.proquest.com/docview/2511247303 |
| Volume | 118 |
| WOSCitedRecordID | wos000629635100068&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NS8MwFA_qPHhR5-f8IoIHPYQ1aZqmJxFxeNCxw5TdSpqkWNjabd38-33pB3oRBC-9pA_C430mv_weQjeejQKtuSCwLAinCSMJCxJilK8hgVCmqrcw7y_hcCgnk2jUHLiVDayyjYlVoDaFdmfkfVcKMw726N_PF8RNjXK3q80IjU3U8aGUcZCucCJ_kO7Kmo0gokTwyGupfUK_P8-VI-uG7MglpfL3-rLKM4O9_-5wH-02FSZ-qE2iizZsfoC6jQ-X-LYhmr47ROPxx7KYJcWsMA6PjrMSOybxHJx-iqGYxTOV5at6hARerLOK-UlbDL-2AFZsc-PecE2diLsEKI_Q2-Bp_PhMmikLREP1tCKSJ5FvpKeDNBCKe1obbmgqfGuYTpmSWogoCP1UUchdEI4s51xVnk7TNNTsGG3lRW5PEeaWUxlB2AIxHoVBEmrXoSTMsNRqGvTQdau5GKzY7UrltliX8bfueuikVn88r-k2YtdEC-h7zv4gfY52mAOdOMCduECdFHzYXqJt_bnKyuVVZR7wHY5evwCUScVE |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Thrombomodulin+is+essential+for+maintaining+quiescence+in+vascular+endothelial+cells&rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences+-+PNAS&rft.au=Giri%2C+Hemant&rft.au=Panicker%2C+Sumith+R&rft.au=Cai%2C+Xiaofeng&rft.au=Biswas%2C+Indranil&rft.date=2021-03-16&rft.issn=1091-6490&rft.eissn=1091-6490&rft.volume=118&rft.issue=11&rft_id=info:doi/10.1073%2Fpnas.2022248118&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1091-6490&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1091-6490&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1091-6490&client=summon |